Cellid Co Ltd

XKRX:299660 (Korea (the Republic of))   Ordinary Shares
â‚© 1935.00 (-0.77%) Jul 16
At Loss
P/B:
0.78
Market Cap:
â‚© 29.27B ($ 21.16M)
Enterprise V:
â‚© 33.84B ($ 24.47M)
Volume:
25.59K
Avg Vol (2M):
159.21K
Trade In:
Volume:
25.59K
At Loss

Business Description

Description
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.
Name Current Vs Industry Vs History
Cash-To-Debt 0.67
Equity-to-Asset 0.6
Debt-to-Equity 0.37
Debt-to-EBITDA -1.8
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.09
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.99
9-Day RSI 36.05
14-Day RSI 34.2
6-1 Month Momentum % -44.22
12-1 Month Momentum % -56.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.99
Quick Ratio 0.98
Cash Ratio 0.85
Days Inventory 261.28
Days Sales Outstanding 142.69
Days Payable 303.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7
Shareholder Yield % 4.44
Name Current Vs Industry Vs History
Gross Margin % 43.18
Operating Margin % -3610.42
Net Margin % -3606.1
FCF Margin % -7423.97
ROE % -39.99
ROA % -23.33
ROIC % -25.05
ROC (Joel Greenblatt) % -34.71
ROCE % -27.72

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 92.93
PB Ratio 0.78
Price-to-Tangible-Book 0.99
EV-to-EBIT -3.32
EV-to-EBITDA -4.44
EV-to-Revenue 107.43
EV-to-FCF -1.47
Earnings Yield (Greenblatt) % -30.16
FCF Yield % -79.89
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cellid Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 314.973
EPS (TTM) (â‚©) -822.93
Beta 1.79
Volatility % 67
14-Day RSI 34.2
14-Day ATR (â‚©) 132.29028
20-Day SMA (â‚©) 2002.674515
12-1 Month Momentum % -56.27
52-Week Range (â‚©) 1758.137987 - 6897.656453
Shares Outstanding (Mil) 15.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cellid Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Cellid Co Ltd Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

Cellid Co Ltd Frequently Asked Questions

What is Cellid Co Ltd(XKRX:299660)'s stock price today?
The current price of XKRX:299660 is â‚©1935.00. The 52 week high of XKRX:299660 is â‚©6897.66 and 52 week low is â‚©1758.14.
When is next earnings date of Cellid Co Ltd(XKRX:299660)?
The next earnings date of Cellid Co Ltd(XKRX:299660) is .
Does Cellid Co Ltd(XKRX:299660) pay dividends? If so, how much?
Cellid Co Ltd(XKRX:299660) does not pay dividend.

Press Release

Subject Date
No Press Release